RT @SABOURETCardio
New anti-diabetic agents: major advances with unanswered questions. #GLP1RA #SGLT2i #T2D https://pubmed.ncbi.nlm.nih.gov/33387991/
RT @SABOURETCardio
Comparing benefits from #SGLT2i and #GLP1RA #MA https://pubmed.ncbi.nlm.nih.gov/35195376/
From Ed Fu et al - but not target trial emulation, this is a propensity score matched analysis
Focusing on safety outcomes
https://journals.lww.com/cjasn/Abstract/9900/Safety_of_Sodium_Glucose_Cotransporter_2.94.aspx in #CJASN
Flozins =
More fracture
More LL amputations
More genital mycotoxins infections
But 1/
RT @SABOURETCardio
#T2D #SGLT2i #GLP1RA #guidelines https://twitter.com/archmedsci/status/1621639268991909888
#T2D #SGLT2i #glp1ra #guidelines
So much information in the supplement of the #Fidelity meta-analysis
https://academic.oup.com/eurheartj/article/43/6/474/6433104?login=false#supplementary-data
➡️This the risk profile of the participants I treat.
➡️It does not matter what their characteristics are, or whether they take other drugs #flozins #GLP1RA.
#Finerenone works the same!
#nephmastodon #endomastodon #cardiomastodon
#ckd #diabetes #cvd
#fidelity #Flozins #glp1ra #finerenone #NephMastodon #endomastodon #cardiomastodon #CKD #diabetes #cvd
Big #GLP1ra week in the #Nephrology clinic for me and my patients. Not a lot of experience with them yet, but no time like the present to start, especially when the #Flozins are already on-board! :smile_animated:
@hswapnil @mike_johansen This is cool! We are working on medication specific guidelines to harmonize prescriptions of #Flozins, #GLP1ra, #nsMRA etc across #primarycare, #cardiology, #endocrinology and #nephrology, which has been a fun project. I think at our institution, nephrology prescribed most aggressively, but that is probably the effect of having Amy Mottl in our division.
#Flozins #glp1ra #nsmra #primarycare #cardiology #Endocrinology #Nephrology